Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease.
Panahloo
A
A
Department of Medicine, University College London Medical School, Whittington, Hospital, UK.
Yudkin
J S
JS
D001161:Arteriosclerosis / Q000235:genetics / Q000503:physiopathology*; D003925:Diabetic Angiopathies / Q000503:physiopathology; D005342:Fibrinolysis / Q000235:genetics / Q000502:physiology*; D005838:Genotype; D005947:Glucose / Q000378:metabolism; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance / Q000502:physiology; D009765:Obesity / Q000150:complications; D017395:Plasminogen Activator Inhibitor 1 / Q000235:genetics / Q000502:physiology; D012307:Risk Factors; D013927:Thrombosis / Q000235:genetics / Q000503:physiopathology*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014280:Triglycerides / Q000378:metabolism; D014652:Vascular Diseases / Q000503:physiopathology
D000960:Hypolipidemic Agents; D017395:Plasminogen Activator Inhibitor 1; D014280:Triglycerides; D010959:Tissue Plasminogen Activator; D005947:Glucose